US deal helps Dechra
Date added:
24/10/2014
ANIMAL pharmaceuticals firm Dechra has seen first quarter revenues jump by 6%. The firm, which is headquartered in Northwich, has benefited from a US acquisition and said the performance was set against a "soft comparator" period when the business was adversely affected by the timing of export orders and supply issues in the US. Most of the growth came from the US where sales leapt by 51%, largely down to the Phycox business it acquired in May for £6m.The company said: "Group trading in the first quarter has been in line with m....
Back to all news